Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana
Open Access
- 15 September 2005
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 4 (1) , 42
Abstract
Background: Both chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) are failing drugs in much of sub-Saharan Africa. Previous findings suggest an association between resistance to CQ and to SP in vivo, in vitro, and on the molecular level. Methods: In 126 Ghanaian children with uncomplicated malaria, associations between mutations conferring resistance in the Plasmodium falciparum dihydrofolate reductase (dhfr; SP) and chloroquine resistance transporter (crt; CQ) genes, concentrations of residual antimalarial drugs, and gametocyte carriage were examined. Results: Mutant dhfr alleles and the CQ-resistance allele crt T76 were strongly associated with each other. Isolates exhibiting the dhfr triple mutation seven times more likely also contained crt T76 parasites as compared to isolates without the dhfr triple variant (P = 0.0001). Moreover, both, isolates with the dhfr triple mutation (adjusted OR, 3.2 (95%CI, 1.0–10.4)) and with crt T76 (adjusted OR, 14.5 (1.4–150.8)) were associated with an increased likelihood of pre-treatment gametocytaemia. However, crt T76 did not correlate with gametocytaemia following SP treatment and no selection of crt T76 in SP treatment failure isolates was observed. Conclusion: These results confirm an association between CQ and SP resistance markers in isolates from northern Ghana. This could indicate accelerated development of resistance to SP if CQ resistance is already present, or vice versa. Considering the enhanced transmission potential as reflected by the increased proportion of isolates containing gametocytes when resistant parasites are present, co-resistance can be expected to spread in this area. However, the underlying mechanism leading to this constellation remains obscure.Keywords
This publication has 30 references indexed in Scilit:
- Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern GhanaTropical Medicine & International Health, 2005
- Short Communication: Limited influence of haptoglobin genotypes on severe malaria in Ghanaian childrenTropical Medicine & International Health, 2005
- A randomized, placebo‐controlled, double‐blind trial on sulfadoxine–pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malariaTropical Medicine & International Health, 2005
- Combination Therapy Counteracts the Enhanced Transmission of Drug-Resistant Malaria Parasites to MosquitoesAntimicrobial Agents and Chemotherapy, 2004
- A study of malaria care provider choice in GhanaHealth Policy, 2004
- Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: Sulfadoxine-pyrimethamine is not working in MalawiBMJ, 2004
- Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective studyBMJ, 2004
- A Molecular Marker for Chloroquine-Resistant Falciparum MalariaNew England Journal of Medicine, 2001
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilizationMolecular Microbiology, 1997